Skip to content

Clinical trials

Withdrawn Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Withdrawn Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20062
20072
20081
20101
20113
20126
20132
20141
20152
20162
20174
20181
20191
20201
20212
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics7
Actelion3
Assistance Publique - Hôpitaux de Paris2
Pfizer2
University of California, Los Angeles2
Akros Pharma Inc.1
Bellerophon Pulse Technologies1
Geno LLC1
Inhibikase Therapeutics1
Jewish General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension37
Hypertension, Pulmonary6
Familial Primary Pulmonary Hypertension2
Idiopathic Pulmonary Fibrosis2
Dyspnea1
Heart Defects, Congenital1
Heart Failure1
Lung Diseases, Interstitial1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.